These findings underscore the potential of probiotic supplementation as a promising assistant therapy for managing obesity and MAFLD and provide valuable insights into its therapeutic mechanisms in metabolic disorders.Yu Mi JoAceBiome Inc 06164 Seoul Republic of KoreaYoon Ji Son...
One miraculous benefit of this probiotic is that according to research Lactobacillus gasseri strain BNR17 extracted from human breast milk promoted weight loss and thus contributing to eliminate the major cause of morbidity and mortality of the world, obesity. And obesity is the major reason for di...
In another study, after receiving Lactobacillus gasseri BNR17, db/db mice displayed an improvement in glucose sensitivity and amelioration of diabetic symptoms such as polydipsia, hyperplasia and polyuria11. We previously demonstrated that oral administration of Lactobacillus reuteri GNML-263 (ADR-3) ...
Irritable bowel syndromeProbioticsLactobacillus gasseriBNR17 is a strain isolated from human breast milk. The objective of this randomized, double-blind, placebo-controlled, and preliminary dose-finding trial was to find the...doi:10.1007/s10068-017-0296-7Kim, Ji Yeon...
gasseri BNR17 may be to due elevated GLUT4 and reduced insulin levels.Ji-HeeR&KangR&Sung-IlR&YunR&Mi-HeeR&ParkR&Jun-HongR&ParkR&So-YoungR&JeongR&EBSCO_AspPLoS ONEKang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO: Anti- obesity effect of Lactobacillus gasseri BNR17 in ...
COMPOSITION FOR TREATING CLIMACTERIC DISORDER COMPRISING LACTOBACILLUS GASSERI BNR17The present invention relates to a pharmaceutical composition for treating climacteric disorder, containing BNR17 according to the present invention has an excellent effect of treating, preventing, or ameliorating various ...
A food composition for preventing or treating diabetes mellitus comprises Lactobacillus gasseri BNR17(deposition no. KCTC 10902BP) as an effective ingredient and is prepared by adding an effective amount of the Lactobacillus gasseri to a food. A pharmaceutical composition for preventing or treating ...
Lactobacillus gasseri BNR17 is a strain isolated from human breast milk. The objective of this randomized, double-blind, placebo-controlled, and preliminary dose-finding trial was to find the effective dose and evaluate the effect of Lb. gasseri BNR17 on irritable bowel syndrome (IBS) symptoms...
Both of the assays developed and validated in this study for the specific identification of Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC strains are specific, sensitive, and precise. These assays can be applied to evaluate and ensure compliance in probiotic products....
Currently, probiotics are used as growth promoters on a large scale to improve the productivity of several animals’ species within the aim of reducing the presence of antibiotic residues in animal products consumed by humans. Several reports evidenced the positive effect of probiotic supplementation on...